Long chain microRNA conjugates in calcium phosphate nanoparticles for efficient formulation and delivery

Archives of Pharmacal Research

Volumn 38, Issue 5, 2015, Pages 705-715

  Jung, Hyosook ^a   Kim, Seung An ^a   Yang, Yong Geun ^a   Yoo, Hyundong ^a   Lim, Soo Jeong ^b   Mok, Hyejung ^a  

^a Konkuk University   (South Korea)

^b Sejong University   (South Korea)

Author keywords

Calcium phosphate nanoparticle; Chemical crosslinking; MicroRNA; Prostate cancer

Indexed keywords

CALCIUM PHOSPHATE; MICRORNA; MIRN34 MICRORNA, HUMAN; NANOPARTICLE;

CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; GENE TRANSFER; HUMAN; MALE; MEDICINAL CHEMISTRY; TUMOR CELL CULTURE;

CALCIUM PHOSPHATES; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE TRANSFER TECHNIQUES; HUMANS; MALE; MICRORNAS; NANOPARTICLES; TUMOR CELLS, CULTURED;

EID: 84939891059     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-014-0451-0     Document Type: Article

References (34)

1. Bouchie, A. 2013. First microRNA mimic enters clinic. Nature Biotechnology 31: 577.
2. Cheng, C.J., and W.M. Saltzman. 2012. Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing. Molecular Pharmaceutics 9: 1481-1488.
3. D'Souza, S.S., et al. 2012. Angiopoietin-2 inhibition using siRNA or the peptide antagonist L1-10 results in antitumor activity in human neuroblastoma. Journal of Cancer Research and Clinical Oncology 138: 2017-2026.
4. Esquela-Kerscher, A., and F.J. Slack. 2006. Oncomirs - microRNAs with a role in cancer. Nature Reviews Cancer 6: 259-269.
5. Grimm, D., et al. 2006. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441: 537-541.
6. Hu, Q.L., et al. 2013. Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model. Biomaterials 34: 2265-2276.
7. Jordan, M., A. Schallhorn, and F.M. Wurm. 1996. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Research 24: 596-601.
8. Kakizawa, Y., S. Furukawa, and K. Kataoka. 2004. Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery. J Control Release 97: 345-356.
9. Kasinski, A.L., and F.J. Slack. 2011. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nature Reviews Cancer 11: 849-864.
10. Kim, W.J., and S.W. Kim. 2009. Efficient siRNA delivery with non-viral polymeric vehicles. Pharmaceutical Research 26: 657-666.
11. Kumar, M.S., et al. 2007. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nature Genetics 39: 673-677.
12. Lee, D., K. Upadhye, and P.N. Kumta. 2012a. Nano-sized calcium phosphate (CaP) carriers for non-viral gene delivery. Materials Science and Engineering B: Advanced 177: 289-302.
13. Lee, S.H., et al. 2012b. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing. Accounts of Chemical Research 45: 1014-1025.
14. Li, J., Y. Yang, and L. Huang. 2012. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. J Control Release 158: 108-114.
15. Liu, C., et al. 2011. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Medicine 17: 211-215.
16. Liu, X.Q., et al. 2012. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth. Molecular Pharmaceutics 9: 2863-2874.
17. Mok, H., et al. 2010. Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nature Materials 9: 272-278.
18. Neumann, S., et al. 2009. The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection. Biomaterials 30: 6794-6802.
19. Ogomi, D., T. Serizawa, and M. Akashi. 2005. Controlled release based on the dissolution of a calcium carbonate layer deposited on hydrogels. J Control Release 103: 315-323.
20. Olton, D., et al. 2007. Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: Influence of the synthesis parameters on transfection efficiency. Biomaterials 28: 1267-1279.
21. Ozen, M., et al. 2008. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793.
22. Pittella, F., et al. 2012. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles. J Control Release 161: 868-874.
23. Rim, H.P., et al. 2011. pH-Tunable calcium phosphate covered mesoporous silica nanocontainers for intracellular controlled release of guest drugs. Angewandte Chemie International Edition 50: 8853-8857.
24. Schickel, R., et al. 2008. MicroRNAs: Key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27: 5959-5974.
25. Schweizer, S., and A. Taubert. 2007. Polymer-controlled, bio-inspired calcium phosphate mineralization from aqueous solution. Macromolecular Bioscience 7: 1085-1099.
26. Shi, S., et al. 2013. Systemic delivery of microRNA-34a for cancer stem cell therapy. Angewandte Chemie (International Edition in English) 52: 3901-3905.
27. Shi, S.J., et al. 2012. Solid lipid nanoparticles loaded with anti-microRNA oligonucleotides (AMOs) for suppression of microRNA-21 functions in human lung cancer cells. Pharmaceutical Research 29: 97-109.
28. Singh, S., et al. 2012. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway. PLoS One 7: e40021.
29. Sokolova, V.V., et al. 2006. Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles. Biomaterials 27: 3147-3153.
30. Szczyrba, J., et al. 2010. The microRNA profile of prostate carcinoma obtained by deep sequencing. Molecular Cancer Research: MCR 8: 529-538.
31. Welch, C., Y. Chen, and R.L. Stallings. 2007. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017-5022.
32. Yamamura, S., et al. 2012. MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. PLoS One 7: e29722.
33. Yang, Q., et al. 2005. pH-Responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chemistry of Materials 17: 5999-6003.
34. Zhang, M.Z., et al. 2009. PEGylated calcium phosphate nanocomposites as smart environment-sensitive carriers for siRNA delivery. Advanced Materials 21: 3520-3525.